1MacLennan A, Lester S, Moore, V. Oral oestrogen replacement therapy versus placebo for hot flushes [ DB/OL ]. Cochrane Library, Date of Most Recent Update: 20-November2002. Date of Most Recent Substantive Update: 19-September-2000
2Lethaby A, Farquhar C, Sarkis A, Roberts H, Jepson R, Barlow D. Hormone replacement therapy in postmenopausal women: endomertial hyperplasia and irregular bleeding ( Cochrane Review) [ DB/OL ]. Cochrane Library, Date of Most Recent Update: 18-November-2002. Date of Most Recent Substantive Update: 24-February-1999
3Norman RJ, Flight IHK, Rees MCP. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution ( Cochrane Review )[DB/OL]. Cochrane Library, Date of Most Recent Update: 20-November-2002. Date of Most Recent Substantive Update: 13-May-1999
4Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV,Johnson .KC, Kotchen JM, Ockene J. Writing group for the Women's Health Initiative investigation. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative Randomized Controlled Trial[J]. JAMA, 2002; 288 (3): 321 - 333
5Al-Azzawi F, Wahab M, Habiba M, Akkad A, Mason T.Continuous combined hormone replacement therapy compared with tibolone [ J ]. Obstetrics & Gynecology, 1999; 93 (2):258 -264
6Kokcu A, Cetinkaya MB, Yanik F, Alper T, Malatyalioglu E.Thecomparison of effects of tibolone and conjugated estrogen-medroxyprogesterone acetate therapy on sexual performance in postmenopausal women [ J]. Maturitas, 2000; 36 ( 1 ): 75-80
7Baracat EC, Barbosa IC, Giordano MG, Haidar MA, Marinho RM, Menegocci JC, Morais KM, Tomaz G, Wehba S. A randomized, open-label study of conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone: effects on symptom control, bleeding pattern, lipid profile and tolerability[J]. Climacteric,2002; 5 ( 1 ): 60 - 69
8Gregoriou O, Vitoratos N, Papadias C, Konidaris S, CostomenosD, Chryssikopoulos A. Effect of tibolone on postmenopausal women with myomas[J]. Maturitas, 1997; 27 (2): 187-191
9Fedele L, Bianchi S, Raffaelli R. Zanconato G. A randomized study of the effects of tibolone and transdermal estrogen replacement therapy in postmenopausal women with uterine myomas [ J ]. European Journal of Obstetrics, Gynecology, & Reproductive Biology,2000; 88(1): 91-94
10Simsek T, Karakus C, Trak B. Impact of different hormone replacement therapy regimens on the size of myoma uteri in postmenopausal period: tibolone versus transdermal hormonal replacement system [ J ]. Maturitas,2002; 42 ( 3 ): 243 - 246
